SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Metropolis Healthcare Ltd

BSE: 542650 NSE: METROPOLIS ISIN: INE112L01020
  |   Sector:  Healthcare   |   Industry:  Hospital & Healthcare Services

Snapshot

Q.1 Which industry/sub-sector does Metropolis Healthcare Ltd belong to?
Metropolis Healthcare Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.
Q.2 Is Metropolis Healthcare Ltd a good quality company?
Metropolis Healthcare Ltd is a good quality company, based on a consistently good 10 year financial track record.
Q.3 Is Metropolis Healthcare Ltd undervalued or overvalued?
Metropolis Healthcare Ltd appears Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Metropolis Healthcare Ltd a good buy now?
Metropolis Healthcare Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd revenue growth is 10.2% for FY-2025 , which is above its 5 year CAGR of 9.2% , indicating faster growth.
Q.2 Gross Profit margin of Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd Gross profit margin which is the profit after deduction of direct costs, is 22.5% for FY-2025 , which is below its 5 year median of 24.1% , indicating decreasing margins.
Q.3 Operating Profit Margin of Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 23.26% for FY-2025 , which is below its 5 year median of 25.74% indicating decreasing margins.
Q.4 Net Profit Margin of Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd Net Profit Margin is 10.93% for FY-2025 , is below with its 5 year median of 12.49%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 22.5 24.1
Operating Profit Margin 23.26 25.74
Net Profit Margin 10.93 12.49
Q.5 Return on Asset of Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd Return on Asset is 7.25%, which is below its 5 year historical median of 8.3%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd Return on equity is 12.07% for FY-2025 , which is below its historical median of 15.46%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd Return on capital employed is 17.59% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 13.5%, indicating value creation.
Q.8 Cash conversion cycle of Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd Cash conversion cycle is -4 days, above its historical median of -4 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.66 0.7
ROE 12.07 15.46
ROCE 17.59 19.83
Cash Conversion Cycle -4 days -4 days
Q.9 Debt to Equity ratio of Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd Debt-to-Equity ratio is 0.01 , which is lower with the industry average of 0.22 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd Debt to cash flow from operations is 0.05 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Metropolis Healthcare Ltd?
Promoters hold 48.88% of the Metropolis Healthcare Ltd, with 1.18% of their stake pledged, indicating low pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Metropolis Healthcare Ltd vs industry peers?
Metropolis Healthcare Ltd revenue CAGR is 9.22% , compared to the industry median CAGR of 1.49% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 1,331.2 144
Gross Profit 299.5 8.2
Operating Profit 308 8.4
Net Profit 146 5
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.66 0.73
ROE 12.07 13.88
ROCE 17.59 17.77
Cash Conversion Cycle (days) -4.24 2

Valuation & price assessment

Q.1 Stock return of Metropolis Healthcare Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of -5.39% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - -5.4% 13.6% 13.3%
Q.3 Valuation ratios of Metropolis Healthcare Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 58.23 19.91 79.71
Price to Book 6.51 9.49 3.54
Price to Sales 6.25 6.83 4.37
EV to EBITDA 25.71 22.12 18.04

Check more companies

1. Aster DM Healthcare
2. Global Health
3. Krishna Inst.Medi
4. Dr. Lal Pathlabs
5. Dr. Agarwals Health
6. RainbowChildrenS Med
7. Vijaya Diagnostic
8. Metropolis Health.
9. Park Medi World
10. HealthcareGlobal
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×